Literature DB >> 18063038

Course of panic disorder during the early postpartum period: a prospective analysis.

Ozkan Guler1, Gulengul N Koken, Murat Emul, Omer Ozbulut, Omer Gecici, Faruk Uguz, Kazim Gezginc, Ismet E Zeytinci, Savas Karatayli, Rustem Askin.   

Abstract

PURPOSE: Most of the studies about course of panic disorder (PD) after childbirth have a retrospective nature. The aim of the current study was to examine prospectively the clinical course of 13 pregnant women with a diagnosis of PD across pregnancy and the early postpartum period.
METHOD: The diagnosis of PD was determined by means of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Axis I Disorders in the third trimester of pregnancy. Within the same period, the Panic and Agoraphobia Scale was used to determine the severity of PD. The last assessment with both instruments was performed at 6 weeks postnatally.
RESULTS: Of these 13 women, 6 (group 1) reported that PD developed during the 6th to the 28th week of their gestation, and the number of women who experienced PD symptoms before pregnancy (group 2) was 7. It was found that the severity of panic symptoms considerably decreased in the total sample, group 1, and group 2 from the basal levels to 6 weeks postnatally.
CONCLUSION: Our study results suggest that pregnant women with PD may experience a marked improvement in PD symptoms in the early postpartum period.

Entities:  

Mesh:

Year:  2007        PMID: 18063038     DOI: 10.1016/j.comppsych.2007.06.007

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  2 in total

1.  Anxiety Disorders Among Women: A Female Lifespan Approach.

Authors:  Liisa Hantsoo; C Neill Epperson
Journal:  Focus (Am Psychiatr Publ)       Date:  2017-04-10

2.  The course and clinical correlates of panic disorder during the postpartum period: a naturalistic observational study.

Authors:  Semra Aydogan; Faruk Uguz; Eda Yakut; Melike G Bayman; Kazim Gezginc
Journal:  Braz J Psychiatry       Date:  2020-10-23       Impact factor: 2.697

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.